New Cell-Based Assays Support Drug Discovery Across the Amylin Receptor Family STATE COLLEGE, PA, UNITED STATES, ...

In the immuno-oncology field, scientists discover, test, and validate novel immunotherapeutic agents that leverage the human immune system to fight cancer, such as checkpoint inhibitors, vaccine-based ...

Scientists use multi-day live cell assays to monitor cell growth, viability, and cytotoxicity when evaluating the effects of drug treatment. However, maintaining consistent cell health over time ...

We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...

The global dry eye syndrome treatment market is projected to record high single-digit growth through 2027. Market expansion is primarily driven by the rising prevalence of dry eye disease, rapid ...

OTC deficiency is a rare genetic condition and the most prevalent urea cycle disorder. Newborns with neonatal onset OTC deficiency exhibit hyperammonemia symptoms shortly after birth, including ...

This article is based on a poster originally authored by Yongyang Huang, Ning Guo, Mackenzie Pierce, Leo Chan, Bo Lin and Yi Yang, which was presented at ELRIG Drug Discovery 2024 in affiliation with ...

Chemicals used in different applications induce genetic and epigenetic aberrations implicated in various diseases, including cancer. Researchers from Japan have developed a cell-based reporter assay ...

Throughput, High-Density CMOS MEA Technology from CytoTronicsThe Associated PressATLANTA ATLANTA–(BUSINESS WIRE)–Jan 22, 2026– Axion BioSystems, a leading life sciences tools company focused on ...

Researchers explored why only 40 percent of patients responded to Amgen's Imdelltra using TellBio's liquid biopsy test and ...